AD
RACGP
Weighing options in obesity management: Surgery vs GLP-1 agonists

Dr Siva Sundararajan

Weighing options in obesity management: Surgery vs GLP-1 agonists

Obesity is a major health burden linked to chronic disease, premature death, and rising healthcare costs. In Australia, 70% of adults are overweight or obese.

Weighing options in obesity management: Surgery vs GLP-1 agonists

Subscribers only

Log in or create a free account to access the full article.

AD